Jelmer Kalisvaart

Experience: Equity Capital Markets: Representing The underwriters of Pharvaris N.V., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies, in respect of its IPO on the Nasdaq Global SelectMarket.; Representing Oppenheimer & Co. Inc. as underwriter and a major investor in connection with a private placement of shares and warrants of Kiadis Pharma N.V., a biopharmaceutical company listed on Euronext Amsterdam and Euronext Brussels.; Representing InterXion Holding N.V., a provider of carrier and cloud neutral colocation data centre services, listed on the NYSE, in respect of an underwritten public offering and listing of shares at the NYSE.; Corporate M&A Transactions: Representing Digital Turbine, Inc. on its acquisition of Fyber N.V., listed on the Frankfurt Stock Exchange, through a block trade followed by a mandatory offer.; Representing InterXion Holding N.V., listed on the NYSE, a leading European provider of cloud and carrier-neutral colocation data center services, in a business combination with Digital Realty, a leading global provider of data center, colocation and interconnection solutions.; Representing A consortium, including PAI Partners SAS and British Columbia Investment Management Corporation in respect of its voluntary public offer for all shares in Refresco Group N.V., listed on Euronext Amsterdam.;